Advanced Therapy of Prostate Disease

Section One: Cancer of the Prostate Epidemiology 1Overview 2African Americans 3Native Africans 4Chinese 5Jamaicans 6Hispanics Assessment of Risk of Prostate Cancer 7Algorithms 8Molecular Risk Screening for Prostate Cancer 9Overview 10Optimal Screening Tests 11Advantages of Screening 12Disadvantages of Screening 13Natural History of Untreated Prostate Cancer 14Physiology of the Prostate 15Pathology of the Prostate 16Animal Models of Prostate Cancer 17Diagnosis of Prostate Cancer 18Staging of Prostate Cancer Treatment 19Patient Preparation 20T1a: Case for Treatment 21T1b-T2: Case for Observation 22T1b-T2: Case for Surgery, Retropubic 23T1b-T2: Perineal Prostatectomy 24T1b-T2: Continence Enhancing Modifications 25T1b-T2: Case for Radiation Therapy 26T1b-T2: Case for Brachytherapy 27T1b-T2: Case for Hormonal Therapy 28T1b-T2: Case for Cryotherapy 29Should T1c Disease Be Treated Differently from T2? 30T3-T4: Case for Observation 31T3-T4: Case for Radiotherapy 32T3-T4: Case for Surgery 33TxN+M0: Case for Observation 34TxN+M0: Case for Radiotherapy 35TxN+M0: Case for Early Hormonal Therapy and Surgery 36NxNxM1: Case for Monotherapy 37TxNxM1: Case for Total Androgen Ablation 38TxNxM1: Is Early Therapy Preferable? 39Staging of Failures of Initial Therapy 40Management of PSA Failure 41Management of Local Failure 42Management of Hormone-Refractory Disease. Second Line Hormones 43Management of Hormone-Refractory Disease. Chemo/Immunotherapy 44Management of Complications Incontinence. Urinary Sphincter 45Management of Complications Incontinence. Contigen 46Management of Complications Impotence 47Management of Complications Rectal Complications 48Chemoprevention of Prostate Cancer 49Management of Complications of the Disease and its Therapy 50Patient Support and Resources 50Summary of Ongoing Clinical Trials Section Two: Benign Prostatic Hyperplasia 51 Molecular Features 52Need for Urodynamics and Other Testing 53Minimal Essential Testing 54 Physiology for the Bladder and Prostate 55Prevention of Benign Prostatic Hyperplasia 56When to Intervene 57Preprocedural Evaluation and Preparation 58Options for Treatment : Alpha Blockers 59Five Alpha Reductase Inhibitors 60Transurethral Needle Ablation 61Contact Laser Prostatectomy 62Noncontact Laser Prostatectomy 63Transurethral Prostatectomy 64Transurethral Incision Prostatectomy 65Open Prostatectomy 66Alternative Medicine Section Three: Prostatitis 67Pathophysiology 68Diagnosis 69Treatment 70Prognosis 71Alternative Therapy